Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) Objectives: mi
R-181a/b and mi
R-410 downregulation and mi
R-155 upregulation has been shown to play
Guan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) treatment of the disease. This study aimed to test our hypothesis that a mi
R-499a played an important role
GAREEV, I.,
YANG, G.,
SUN, J.,
BEYLERLI, O.,
CHEN, X.,
ZHANG, D.,
ZHAO, B.,
ZHANG, R.,
SUN, Z.,
YANG, Q.,
LI, L.,
ZHAO, S.,
PAVLOV, V.,
SAFIN, S. (2020) explored the circulating plasma microRNA (mi
R)-181b, mi
R-223, mi
R-155, and mi
R-145 as new potential